{"id":"https://openalex.org/W2182820439","doi":null,"title":"Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.","display_name":"Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-11-01","ids":{"openalex":"https://openalex.org/W2182820439","mag":"2182820439","pmid":"https://pubmed.ncbi.nlm.nih.gov/17203758"},"language":"en","primary_location":{"id":"pmid:17203758","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17203758","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Clinical Trial, Phase II"},"parent_works":[],"lineage":["https://openalex.org/W2182820439"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034751834","display_name":"Franco Di Filippo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Franco Di Filippo","raw_affiliation_strings":["Regina Elena National Cancer Institute, Rome, Italy. difilippo@ifo.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regina Elena National Cancer Institute, Rome, Italy. difilippo@ifo.it","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008759910","display_name":"Carlo Riccardo Rossi","orcid":"https://orcid.org/0000-0001-7875-5655","observed_orcids":["https://orcid.org/0000-0001-7875-5655"]},"institutions":[{"id":"https://openalex.org/I4210109345","display_name":"Istituto Oncologico Veneto","ror":"https://ror.org/01xcjmy57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109345","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlo Riccardo Rossi","raw_affiliation_strings":["Istituto Oncologico Veneto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico Veneto","institution_ids":["https://openalex.org/I4210109345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087113555","display_name":"Mario Santinami","orcid":"https://orcid.org/0000-0001-8436-4757","observed_orcids":["https://orcid.org/0000-0001-8436-4757"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mario Santinami","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079811406","display_name":"Francesco Cavaliere","orcid":"https://orcid.org/0000-0001-6501-8648","observed_orcids":["https://orcid.org/0000-0001-6501-8648"]},"institutions":[{"id":"https://openalex.org/I4210130664","display_name":"IRCCS San Camillo Hospital","ror":"https://ror.org/03njebb69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210130664","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesco Cavaliere","raw_affiliation_strings":["San Camillo Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Camillo Hospital","institution_ids":["https://openalex.org/I4210130664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061463918","display_name":"Rosa Garinei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rosa Garinei","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004471127","display_name":"M Anz\u00e0","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele Anz\u00e0","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021898630","display_name":"Pasquale Perri","orcid":"https://orcid.org/0000-0002-2416-3299","observed_orcids":["https://orcid.org/0000-0002-2416-3299"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pasquale Perri","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019614566","display_name":"Claudio Botti","orcid":"https://orcid.org/0000-0002-5814-6876","observed_orcids":["https://orcid.org/0000-0002-5814-6876"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudio Botti","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086853668","display_name":"Piera Di Angelo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Piera Di Angelo","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111500265","display_name":"Rossella Pasqualoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rossella Pasqualoni","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108108366","display_name":"Simona Di Filippo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simona Di Filippo","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5264,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.67754602,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"20","issue":"6A","first_page":"739","last_page":"742"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.022199999541044235,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9610000252723694},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.6790000200271606},{"id":"https://openalex.org/keywords/patient-selection-criteria","display_name":"patient selection criteria","score":0.6349999904632568},{"id":"https://openalex.org/keywords/stage-iii-melanoma","display_name":"stage III melanoma","score":0.6010000109672546},{"id":"https://openalex.org/keywords/regional-lymph-node-metastasis","display_name":"regional lymph node metastasis","score":0.5},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.47999998927116394},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.4779999852180481},{"id":"https://openalex.org/keywords/unresectable-melanoma","display_name":"unresectable melanoma","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8543502688407898},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.7441295385360718},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5746521353721619},{"id":"https://openalex.org/C146957229","wikidata":"https://www.wikidata.org/wiki/Q1266915","display_name":"Perfusion","level":2,"score":0.5583547353744507},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.5159190893173218},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4925156533718109},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4866243302822113},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4486916661262512},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4442501962184906},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4295906126499176},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.41988348960876465},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.41317838430404663},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.34599125385284424},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3433305621147156},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.323326051235199},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21255028247833252},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005121","descriptor_name":"Extremities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006979","descriptor_name":"Hyperthermia, Induced","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010478","descriptor_name":"Chemotherapy, Cancer, Regional Perfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17203758","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17203758","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Clinical Trial, Phase II"},{"id":"mag:2182820439","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17203758","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1968401667","https://openalex.org/W1980628003","https://openalex.org/W2007984865","https://openalex.org/W2012023886","https://openalex.org/W2065807715","https://openalex.org/W2094264677","https://openalex.org/W2413882441"],"related_works":["https://openalex.org/W2094264677","https://openalex.org/W2464854354","https://openalex.org/W2116633450","https://openalex.org/W2184712928","https://openalex.org/W2413882441","https://openalex.org/W2131887263","https://openalex.org/W2041947339","https://openalex.org/W2397516084","https://openalex.org/W1980628003"],"abstract_inverted_index":{"BACKGROUND:":[0],"Hyperthermic":[1],"isolation":[2],"limb":[3,274,288,312],"perfusion":[4],"(HILP)":[5],"with":[6,92,124,162,199,220,229,327,386,394],"tumor":[7,128,245,339,381],"necrosis":[8],"factor":[9,376],"alpha":[10],"(TNFalpha)":[11],"and":[12,18,72,101,115,130,145,212,227,241,248,270,278,286,294,307,319,324,345],"IFNgamma":[13],"was":[14,24,122,159,191,253,290,314,363,372],"pioneered":[15],"by":[16,267],"Li\u00e9nard":[17],"Lejeune":[19],"in":[20,89,169,186,207,214,255,292],"1988.":[21],"The":[22,58,132,189,317,369],"TNFalpha":[23,70,102,138,222,252,347,395],"empirically":[25],"employed":[26],"at":[27,103,259,396],"a":[28,97,116,153,179,200,221,304,397],"dosage":[29,223,348],"of":[30,60,99,120,134,137,150,168,181,209,246,273,296,301,331,400],"3-4":[31],"mg,":[32,357],"that":[33],"is":[34,63],"ten":[35],"times":[36],"the":[37,69,140,148,187,210,233,256,260,297,337,346,366,373,380],"systemic":[38],"maximum":[39],"tolerated":[40],"dose":[41,71,133,399],"(MTD).":[42],"After":[43],"eighteen":[44],"years":[45],"from":[46,106,392],"its":[47],"first":[48],"clinical":[49],"application,":[50],"more":[51],"than":[52],"300":[53],"patients":[54,91,112,183,211,217,234,302,385],"have":[55],"been":[56,87],"treated.":[57],"aim":[59],"this":[61,151],"study":[62,84,158],"to":[64,108,237,335,378],"clarify":[65],"two":[66,367],"major":[67],"arguments:":[68],"eligibility":[73],"criteria":[74],"for":[75,244,276],"patient":[76],"selection.":[77],"PATIENTS":[78],"AND":[79],"METHODS:":[80],"A":[81,283],"phase":[82,155],"I-II":[83],"has":[85],"previously":[86],"conducted":[88],"20":[90],"in-transit":[93],"melanoma":[94,388],"metastases":[95,171],"using":[96],"combination":[98],"melphalan":[100,268],"dosages":[104],"ranging":[105],"0.5":[107],"3.3":[109],"mg.":[110,231,402],"Twenty":[111],"were":[113,176,184,218,235,322],"treated":[114,219],"complete":[117,318],"pathological":[118],"response":[119,129,330,340],"70%":[121],"recorded,":[123],"no":[125,359],"correlation":[126],"between":[127,365],"TNFalpha.":[131],"1":[135,225,230,285,352,356,401],"mg":[136,226,353],"provided":[139],"best":[141],"results":[142,152],"regarding":[143],"efficacy":[144],"toxicity.":[146],"On":[147],"basis":[149],"large":[154],"II":[156],"SITILO":[157],"undertaken.":[160],"Patients":[161],"stage":[163],"IIIA":[164],"-":[165],"IIIAB":[166],"(presence":[167],"transit":[170],"and/or":[172],"regional":[173],"node":[174],"involvement)":[175],"considered":[177],"eligible;":[178],"total":[180],"113":[182],"enrolled":[185],"study.":[188],"disease":[190,371,389],"bulky":[192,370,387],"(>":[193],"10":[194,271],"nodules":[195,198],"or":[196,203,342,350,354],"fewer":[197],"diameter":[201],">":[202,224,355],"=":[204,351],"3":[205,306],"cm)":[206],"42.5%":[208],"unresectable":[213],"33%.":[215],"Forty":[216],"73":[228],"All":[232],"submitted":[236],"HILP":[238,393],"via":[239],"axillary":[240],"iliac":[242],"vessels":[243],"upper":[247,277],"lower":[249,279],"limb,":[250],"respectively.":[251],"injected":[254],"extracorporal":[257],"circuit":[258],"pre-established":[261],"dose,":[262],"followed":[263],"after":[264],"30":[265],"minutes":[266],"(13":[269],"mg/L":[272],"volume":[275],"limbs,":[280],"respectively).":[281],"RESULTS:":[282],"grade":[284,305,310],"2":[287],"toxicity":[289,313],"found":[291,364],"52.9%":[293],"30.1%":[295],"patients,":[298],"respectively,":[299,326],"5.5%":[300],"exhibited":[303],"4,":[308],"whereas":[309],"5":[311],"not":[315,343],"found.":[316],"partial":[320],"responses":[321],"63%":[323],"24.5%,":[325],"an":[328],"objective":[329],"87.5%.":[332],"We":[333],"tried":[334],"correlate":[336],"typed":[338],"(CR":[341],"CR)":[344],"<":[349],"but":[358],"statistically":[360],"significant":[361],"difference":[362],"groups.":[368],"only":[374],"prognostic":[375],"able":[377],"influence":[379],"response.":[382],"CONCLUSION:":[383],"Only":[384],"can":[390],"benefit":[391],"low":[398]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2182820439","counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
